IDHS/SUPR Drug Overdose Prevention Program

The Illinois Department of Human Services, Division of Substance Use Prevention and Recovery (IDHS/SUPR) aims to reduce the number of opioid overdoses through the expansion of community-based Overdose Education and Naloxone Distribution (OEND). OEND is an evidence-based method for reducing opioid overdose deaths. In order to expand overdose education and naloxone distribution, IDHS/SUPR manages the Drug Overdose Prevention Program (DOPP). By registering to become a DOPP, organizations can order and distribute naloxone (Narcan nasal spray), a safe and effective opioid overdose reversal medication that saves lives.

DOPP- enrolled programs are responsible for training and education, maintaining a supply of naloxone, and reporting information into the DOPP portal. These programs are essential to ending the overdose crisis in Illinois by making sure that anybody who may witness an opioid overdose is equipped with naloxone and the knowledge they need to save a life.


Order Narcan:

IMPORTANT: Click the Hospital & Clinics button below only if you have a Medical Director (or prescribing staff member) who can write a standing prescription order for naloxone for the organization/site. If you do not have such a person in your organization, then please click on the Community Organizations button.

Hospitals & Clinics Access Narcan (click here)

Community Organizations Access Narcan (click here)


Prospective DOPPs include:

  • SUPR-licensed substance use treatment programs
  • Recovery homes
  • Local public health departments
  • Hospitals and Clinics
  • Educational facilities
  • County Jails
  • Not-for-profit community-based organizations
  • Urgent care facilities
  • Faith-based organizations
  • Police departments
  • Local businesses
  • Federally Qualified Health Centers

* Individuals please click here.


Locate Existing Drug Overdose Prevention Programs


Reporting

Overdose reversal and naloxone administration data is submitted using the DOPP Portal: https://www.ilsavesod.org/ . SUPR uses this data to report to our funder, the Substance Abuse and Mental Health Services Administration, SAMHSA. By consistently reporting this data, you are contributing to our efforts to meet goals, target areas in need, and ultimately help save lives. The reports below show trends over time in the program. They are updated monthly. If you need additional information, contact DHS.DOPP.Coordinator@Illinois.gov 


DOPP and Naloxone Informational Materials

Provider Training and Education

Naloxone and Overdose Education

Family and Friends Support


Individuals

It is recommended that you carry naloxone if you or a loved one are prescribed and/or use opioids. Illinois Public Act 099-0480 became effective September 9, 2015 as an enhancement to Illinois Public Act 096-0361, enabling nonmedical personnel to administer naloxone without liability. Anyone in Illinois can get trained to carry and administer naloxone. Most insurance will cover some or all of the cost of generic naloxone and/or Narcan brand naloxone nasal spray.

Illinois' Good Samaritan Law (PA-096-0361) took effect in 2010, making it legal in Illinois for non-medical persons to administer the drug overdose reversal medication Naloxone to another individual in order to prevent an opioid/heroin overdose from becoming fatal.

Due to the Statewide Naloxone Standing Order in Illinois, Naloxone is available at pharmacies and DOPPs. Use the Illinois Department of Public Health's Opioid Data Dashboard to find naloxone distribution sites near you: Opioid Data Dashboard. You can also inquire at your local pharmacy and ask them to order it for you. When buying naloxone, the price can vary greatly depending on your insurance plan and the type you want to buy. Nasal Naloxone is more expensive, but easier to carry and use.

If you or a loved one is struggling with substance use, help is here. Contact the Illinois Helpline at 1-833-234-6343 or www.helplineil.org 

Optional: Organizations with their own medical directors can use this template to generate an internal Standing Order (IL 444-2052).


Contact Information